Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis

BK Tan, S Mainbourg, A Friggeri, L Bertoletti… - Thorax, 2021 - thorax.bmj.com
Background The prevalence of venous thromboembolic event (VTE) and arterial
thromboembolic event (ATE) thromboembolic events in patients with COVID-19 remains …

The risk of postoperative complications after major elective surgery in active or resolved COVID-19 in the United States

JZ Deng, JS Chan, AL Potter, YW Chen… - Annals of …, 2022 - journals.lww.com
Objective: To assess the association between the timing of surgery relative to the
development of Covid-19 and the risks of postoperative complications. Summary …

Microvascular angiopathic consequences of COVID-19

M Nalugo, LJ Schulte, MF Masood… - Frontiers in …, 2021 - frontiersin.org
The coronavirus disease-2019 (COVID-19) pandemic has rapidly spread across the world.
The disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Pulmonary embolism in patients with COVID-19 and value of D-dimer assessment: a meta-analysis

RM Kwee, HJA Adams, TC Kwee - European radiology, 2021 - Springer
Purpose To investigate, in a meta-analysis, the frequency of pulmonary embolism (PE) in
patients with COVID-19 and whether D-dimer assessment may be useful to select patients …

SARS-CoV-2 infection and cardioncology: from cardiometabolic risk factors to outcomes in cancer patients

V Quagliariello, A Bonelli, A Caronna, G Conforti… - Cancers, 2020 - mdpi.com
Simple Summary The coronavirus disease-2019 (COVID-19) pandemic has significantly
changed the management and treatment of some diseases, including cancer, in order to …

Reduced macular vessel density in COVID-19 patients with and without associated thrombotic events using optical coherence tomography angiography

N Guemes-Villahoz, B Burgos-Blasco… - Graefe's Archive for …, 2021 - Springer
Purpose Thrombotic events (TE) represent one of the major complications of SARS-CoV-2
infection. The objective is to evaluate vessel density (VD) and perfusion density (PD) by …

[HTML][HTML] Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID‐19: a single‐center prospective longitudinal study

GK Juneja, M Castelo, CH Yeh, SE Cerroni… - Journal of thrombosis …, 2021 - Elsevier
Background Immunothrombosis and coagulopathy in the lung microvasculature may lead to
lung injury and disease progression in coronavirus disease 2019 (COVID‐19). We aim to …

Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19

AK Pasha, RD McBane, R Chaudhary, LJ Padrnos… - Thrombosis research, 2021 - Elsevier
Background The reported incidence of venous thromboembolism (VTE) in COVID-19
patients varies widely depending on patient populations sampled and has been …

Deep vein thrombosis and pulmonary embolism among hospitalized coronavirus disease 2019–positive patients predicted for higher mortality and prolonged …

Y Erben, C Franco-Mesa, P Gloviczki, W Stone… - Journal of Vascular …, 2021 - Elsevier
Objective We assessed the incidence of deep vein thrombosis (DVT) and pulmonary
embolism (PE) in hospitalized patients with coronavirus disease 2019 (COVID-19) …

The balance of comprehensive coagulation and fibrinolytic potential is disrupted in patients with moderate to severe COVID-19

T Onishi, N Shimonishi, M Takeyama… - International Journal of …, 2022 - Springer
Coagulation and fibrinolytic mechanisms are enhanced in patients with coronavirus (COVID-
19), but disturbances in the balance of both functions in COVID-19 patients remain unclear …